Itraconazole Capsule: Clinical Trials

14 trials of Itraconazole Capsule, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 unknown, 1 not yet recruiting. 11 Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 111Completed 9, Not yet recruiting 1, Unknown 1
Not applicable1Unknown 1
Phase 21Completed 1
Phase 31Completed 1

Follow Itraconazole Capsule: new trials by email Literature Review of Itraconazole Capsule trials Research Report on Itraconazole Capsule

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug Interaction and Food Effect Study of CS0159
CS0159 Tablet, Rifampicin Capsule, Itraconazole Capsule - Healthy Volunteers
Phase 1CompletedCascade Pharmaceuticals, Inc322026-03-092026-06-03
Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers
AL3818 Capsule, Itraconazole capsule, Ticagrelor Tablets - Healthy Volunteer
Phase 1Not yet recruitingAdvenchen Laboratories Nanjing Ltd.162026-03-022026-02-27
A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants
HRS-8080 Tablet, Itraconazole Capsule - Breast Cancer
Phase 1CompletedShandong Suncadia Medicine Co., Ltd.162025-11-262026-01-14
A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
TQB3909 tablets, Itraconazole capsule, Rifampicin capsule - Advanced Malignant Neoplasm
Phase 1UnknownChia Tai Tianqing Pharmaceutical Group Co., Ltd.402023-12-012023-12-12
A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule - Myelofibrosis
Phase 1CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.402023-09-212025-12-12
Itraconazole in Advanced Ovarian Cancer
Itraconazole capsule, Placebo - Ovarian Carcinoma
Not applicableUnknownTanta University662022-10-012022-10-24
A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers
Jaktinib Hydrochloride Tablets, Itraconazole capsule, Rifampicin Capsules - Healthy Volunteers
Phase 1CompletedSuzhou Zelgen Biopharmaceuticals Co.,Ltd402021-10-272024-02-07
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Venetoclax 100 MG, Itraconazole capsule, Azacitidine Injection - AML
Phase 2CompletedHospital Universitario Dr. Jose E. Gonzalez152021-07-262023-01-25
Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.
Terbinafine Pill, Itraconazole capsule - Dermatophyte Infection, Terbinafine Adverse Reaction
Phase 3CompletedPak Emirates Military Hospital1202021-03-152022-04-01
Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects
SHR6390 tablet, Itraconazole capsule - Healthy Subjects
Phase 1CompletedJiangsu HengRui Medicine Co., Ltd.182020-06-102021-10-18
A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711
BPI-7711, Itraconazole, Rifampicin - NSCLC
Phase 1CompletedBeta Pharma, Inc.312019-12-122021-04-22
Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects
pyrotinib tablet, Itraconazole capsule - Healthy Subjects
Phase 1CompletedJiangsu HengRui Medicine Co., Ltd.182019-09-182020-07-21
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
Omaveloxolone, Midazolam oral solution, Repaglinide 1 MG - Healthy Adult Subjects
Phase 1CompletedBiogen612019-06-142025-05-30
Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule - Infections, Bacterial
Phase 1CompletedGlaxoSmithKline462014-01-282017-07-13

Conditions studied

Bacterial Infections (1)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Dermatomycoses (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Ovarian Neoplasms (1)  ·  Primary Myelofibrosis (1)

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2)  ·  Jiangsu HengRui Medicine Co., Ltd. (2)  ·  Advenchen Laboratories Nanjing Ltd. (1)  ·  Beta Pharma, Inc. (1)  ·  Biogen (1)  ·  Cascade Pharmaceuticals, Inc (1)  ·  GlaxoSmithKline (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Pak Emirates Military Hospital (1)  ·  Shandong Suncadia Medicine Co., Ltd. (1)  ·  Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1)  ·  Tanta University (1)

Countries

China (9)  ·  United States (2)  ·  Egypt (1)  ·  Mexico (1)  ·  Pakistan (1)

Top investigators

David Gomez-Almaguer (1)  ·  Dr. Umar Abdul Ali Qureshi, MBBS (1)  ·  Jason Wu (1)  ·  Jennifer Zon, MD (1)  ·  Jingying Jia (1)  ·  Qing He (1)  ·  Tarek M Mostafa, Professor (1)  ·  Yun Liu (1)

Results publications

PMID 35769034, PMID 37633156